01 · Process stage
PlannedMaterial dispensing & preparation
Define material physical properties, necessary segregation measures and appropriate initial dispensing controls.
Capabilities · Oral solid dosage forms
Tablets
A proposed service scope for compressed solid dosage forms, connecting formulation evaluation, blending, granulation, compression and potential coating stages.
PlannedCatalogue scope
Service statusPlanned
Planned.
Technical boundaries and readiness need confirmation before an activity could be presented as available.
Basis · Catalogue scope
- Status
- PlannedNo available service asserted
- Source-plan relationship
- Catalogue scopeProposed catalogue expansion
- Readiness
- Not establishedProduct and process evidence needed
- Facility roadmap
- First commercial batch target Q1 2028 · indicativeNot a service date
01 · Proposed service scope
Start with the product and its container.
Tablet manufacturing is presented as a planned service domain. The exact product characteristics, active ingredient properties, chosen technical route and presentation requirements would define its specific technical scope.
The initial Boten formulation-and-filling plan focuses on specific sterile parenteral formats and protein raw-material processing. Proposed oral solid dosage services lie outside that initial plan and would need separate scope confirmation.
Direct compression, wet granulation and dry granulation represent distinct pathways. A shared catalogue entry does not establish that any single preparation route is appropriate for a proposed formulation.
Catalogue boundary
A planned catalogue for scoped evaluation. Inclusion does not establish installed, qualified, licensed or available capability.
02 · Presentation families
Match the route to the format.
| Format | Planning note | Basis | Status |
|---|---|---|---|
| Uncoated immediate-release tablets | Conventional compressed forms proposed as an extension to the initial project scope. | Catalogue scope | Planned |
| Film-coated tablets | Aqueous or organic coating processes would require defined equipment and safety evaluation. | Catalogue scope | Planned |
| Modified-release tabletsModified-release & oral films | Extended or delayed release profiles require specific formulation or functional coating steps. | Catalogue scope | Planned |
03 · Process scope for discussion
Make the sequence and its evidence visible.
02 · Process stage
PlannedBlending & granulation evaluation
Consider the blending parameters and any requirement for wet or dry granulation steps.
03 · Process stage
PlannedTablet compression parameters
Establish target weight, hardness, friability and the specific tooling requirements for compression.
04 · Process stage
PlannedCoating process definition
Assess the need for functional or non-functional film coating and the associated drying conditions.
05 · Process stage
PlannedIn-process testing & control
Define sampling plans, physical testing requirements and acceptable limits during the compression run.
06 · Process stage
PlannedBulk packing & review
Connect the manufacturing record, physical test results and the accountable disposition of the bulk material.
Illustrative sequence
This is a technical discussion structure, not an operating procedure, approved process flow or representation of installed equipment.
04 · Supporting services
No service stands alone.
01PlannedCatalogue scope
Preformulation & formulation development
Material properties, formulation options and product-specific development questions.
Explore proposed scope02PlannedCatalogue scope
Primary packaging
Blisters, bottles, sachets, tubes and presentation-specific container systems.
Explore proposed scope03PlannedCatalogue scope
Powders & granules
Blending, granulation, unit-dose sachets and bulk presentations.
Explore proposed scope05 · Readiness questions
A service claim needs a defined evidence base.
- Formulation & physical properties
- Exact qualitative and quantitative composition alongside relevant powder flow characteristics.
- Facility & processing systems
- Appropriate processing suites, environmental containment controls and an agreed technical scope.
- Process control evidence
- Defined critical process parameters and suitable evidence of mixing uniformity.
- Quality responsibilities
- Agreed sampling protocols, analytical responsibilities and formal review decision rights.
- Regulatory context
- Applicable permissions for handling the specific active substance and excipients.
- Technical agreement
- Documented responsibilities, intellectual property boundaries and disclosure terms for engagement.
06 · Practical questions
Before a technical discussion.
Is this service currently available?
No. The service is Planned. This page is a scope proposal and does not establish an operating tablet manufacturing service.
Are oral solid dosage forms part of the initial plan?
No. The initial plan details sterile parenteral presentations. Tablets and other oral solid forms require separate scope confirmation.
What information helps define the question?
Identify the proposed formulation, physical properties, development stage, intended destination and the technical question. Confidential data should only be shared through an agreed route.
Is there a service launch quarter?
No. No service-specific quarter is established. The project-wide indicative milestones do not commit any individual service to a start date.
Does a technical discussion establish supply?
No. Feasibility, scope, permissions, evidence and any agreement would need to be established before a service or supply commitment.
Professional enquiries
Discuss a defined question.
Describe the presentation, development question and destination relevant to the proposed scope. Do not infer service availability from this planning page.